Safety and Immunogenicity of an Inactivated Influenza A/H5N1 Vaccine Given with or without Aluminum Hydroxide to Healthy Adults: Results of a Phase I–II Randomized Clinical Trial

Wendy A. Keitel1 James D. Campbell2 John J. Treanor4 Emmanuel B. Walter5 Shital M. Patel1 Fenhua He3 Diana L. Noah6 and Heather Hill3

首页> 外文期刊>Journal of Infectious Diseases >Safety and Immunogenicity of an Inactivated Influenza A/H5N1 Vaccine Given with or without Aluminum Hydroxide to Healthy Adults: Results of a Phase I–II Randomized Clinical Trial

【24h】

Safety and Immunogenicity of an Inactivated Influenza A/H5N1 Vaccine Given with or without Aluminum Hydroxide to Healthy Adults: Results of a Phase I–II Randomized Clinical Trial

机译：健康成年人使用或不使用氢氧化铝的灭活甲型/ H5N1流感疫苗的安全性和免疫原性：I–II期随机临床试验的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background. Dose-sparing strategies are being explored for vaccines against pandemic influenza. We evaluated the dose-sparing potential of aluminum hydroxide (AlOH) adjuvant.

机译：背景。正在研究针对大流行性流感疫苗的节省剂量策略。我们评估了氢氧化铝（AlOH）佐剂的降低剂量的潜力。

著录项

来源
《Journal of Infectious Diseases》 |2008年第9期|p.1309-1316|共8页
作者
Wendy A. Keitel1 James D. Campbell2 John J. Treanor4 Emmanuel B. Walter5 Shital M. Patel1 Fenhua He3 Diana L. Noah6 and Heather Hill3;
展开▼
作者单位

1 Baylor College of Medicine, Houston, Texas 2 University of Maryland School of Medicine, Baltimore 3 The EMMES Corporation, Rockville, Maryland 4 University of Rochester, Rochester, New York 5 Duke University Medical Center, Durham, North Carolina 6 Southern Research Institute, Birmingham, Alabama;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial. [J] . Keitel WA, Campbell JD, Treanor JJ, The Journal of Infectious Diseases . 2008,第9期

机译：健康成年人服用含或不含氢氧化铝的灭活A / H5N1流感灭活疫苗的安全性和免疫原性：I-II期随机临床试验的结果。
2. Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged = 18 years: A phase III, randomized trial [J] . Tinoco Juan Carlos, Pavia-Ruz Noris, Cruz-Valdez Aurelio, Vaccine . 2014,第13期

机译：≥18岁健康成年人体内灭活的四价流感疫苗候选物与灭活的三价流感疫苗的免疫原性，反应原性和安全性：III期随机试验
3. Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults [J] . Brady Rebecca C, Treanor John J, Atmar Robert L, Vaccine . 2009,第37期

机译：健康老年人中亚病毒灭活的带有或不带有氢氧化铝的亚病毒灭活的A / H5N1流感疫苗的安全性和免疫原性
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. Bayesian Sequential Randomization Designs for Phase III Clinical Trials. [D] . Zhu, Han. 2016

机译：III期临床试验的贝叶斯顺序随机设计。
6. Safety and Immunogenicity of an Inactivated Influenza A/H5N1 Vaccine Given with or without Aluminum Hydroxide to Healthy Adults: Results of a Phase I—II Randomized Clinical Trial [O] . Wendy A. Keitel, James D. Campbell, John J. Treanor, -1

机译：健康成年人使用或不使用氢氧化铝的灭活甲型/ H5N1流感疫苗的安全性和免疫原性：I-II期随机临床试验的结果
7. Safety and Immunogenicity of an Inactivated Influenza A/H5N1 Vaccine Given with or without Aluminum Hydroxide to Healthy Adults: Results of a Phase I–II Randomized Clinical Trial [O] . Wendy A. Keitel, James D. Campbell, John J. Treanor, 2008

机译：灭活的流感A / H5N1疫苗的安全性和免疫原性或没有氢氧化铝至健康成人的疫苗：I-II期随机临床试验的结果
8. Randomized Double-Blind Phase III Pivotal Field Trial of the Comparative Immunogenicity Safety and Tolerability of Two Yellow Fever 17D Vaccines (ARILVAX(Trademark) and YF-VAX(Trademark)) in Healthy Infants and Children in Peru [R] . Belmusto-Worn, V. E. , Sanchez, J. L. , McCarthy, K. , 2004

机译：秘鲁健康婴儿和儿童两种黄热病17D疫苗（aRILVaX（商标）和YF-VaX（商标））的比较免疫原性安全性和耐受性的随机双盲III期关键现场试验

Safety and Immunogenicity of an Inactivated Influenza A/H5N1 Vaccine Given with or without Aluminum Hydroxide to Healthy Adults: Results of a Phase I–II Randomized Clinical Trial

摘要

著录项

相似文献

相关主题

期刊订阅